D-0823-2021 Class II Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

Recall Details

Product Type
Drugs
Report Date
September 29, 2021
Initiation Date
August 27, 2021
Termination Date
October 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1800 bottles

Product Description

Chlorzoxazone Tablets USP 375 mg 100 Tablets Rx Only NDC 68462-724-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

Reason for Recall

CGMP Deviations

Distribution Pattern

Nationwide.

Code Information

Lots: 29200022 Exp. 03/31/2022; 29200024 Exp. 03/31/2022; 29200035 Exp. 06/30/2022